Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc. is a biotechnology startup focused on leveraging its proprietary technology platform called GEODe™ to discover and develop therapeutic proteins and antibodies targeting G-Protein Coupled Receptors (GPCRs). The company's slogan "Transforming the discovery of novel GPCR-targeted therapies" encapsulates its mission to address unmet medical needs by developing innovative biologic medicines.

Founded in 2019 and headquartered in the United States, Tectonic Therapeutic, Inc. aims to revolutionize the pace of innovation in the field of GPCR-targeted therapies. By targeting areas of significant unmet medical need, the company seeks to provide novel treatment options where current therapeutic choices are inadequate or non-existent, ultimately enhancing patient quality of life.

Currently, there is no available data on the last investment or the participating investors, indicating that the company may be in the early stages of attracting external funding for its groundbreaking research and development initiatives.